CCM
AUPH icon

Cutler Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cutler Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-55,000
Closed -$254K – 92
2018
Q3 		$254K Hold
55,000
– – 0.11% 81
2018
Q2 		$310K Hold
55,000
– – 0.13% 77
2018
Q1 		$285K Buy
55,000
+5,000
+10% +$26.8K 0.12% 89
2017
Q4 		$226K Buy
50,000
+10,000
+25% +$55.5K 0.09% 92
2017
Q3 		$251K Buy
40,000
+10,000
+33% +$63K 0.11% 73
2017
Q2 		$184K Buy
+30,000
New +$202K 0.09% 69

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cutler Capital Management's AUPH Position: Q4 2018 in Review

Cutler Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2018, closing a stake of 55,000 shares — an estimated $254K sold.

Cutler Capital Management first reported a position in AUPH in Q2 2017 and held it in 6 quarters. The position peaked at $310K in Q2 2018. 61 funds tracked by Wall St. Rank hold AUPH as of Q4 2018.

  • Cutler Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Cutler Capital Management sold 55,000 Aurinia Pharmaceuticals shares in Q4 2018, an estimated $254K.
  • Cutler Capital Management first reported a position in Aurinia Pharmaceuticals in Q2 2017 and held it in 6 quarters.
  • Cutler Capital Management's Aurinia Pharmaceuticals position peaked at $310K in Q2 2018.
  • 61 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2018.

Based on Cutler Capital Management's 13F filing for Q4 2018, filed 25 Jan 2019.